Lagrangeville, NY, United States of America

Nicholas J Papadopoulos

This inventor holds 93 USPTO granted patents and 33 published patent applications, plus 16 CIPO patents and 28 EPO patents, primarily in Antibody Therapeutics (CPC class C07K2317-21). Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2006-2026.

USPTO Granted Patents = 93 (Patent Applications = 33)

% Patents Active = 83.9

CIPO Patents = 16 (Patent Applications = 2)

EPO Patents = 28 (Patent Applications = 28)

Average Co-Inventor Count = 3.9

ph-index = 33

Forward Citations = 2,953(Granted Patents)

Forward Citations (Not Self Cited) = 2,721(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

LaGrangeville, NY (US) (2006 - 2023)
The Woodlands, TX (US) (2021 - 2024)

Company Filing History:

90 out of 1,479

Regeneron Pharmaceuticals, Inc.

patents

3 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

IL-33 Antagonists

Anti-CD3 Antibodies

Human IL-6 Receptor

PD-1 Antibodies

PD-L1 Antibodies

Antibody-Drug Conjugates

Chimeric Polypeptides

Prolactin Receptor

Cancer Treatments

Multispecific Molecules

Nucleic Acids

93 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12600780 - Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind CD3 and CD20, and Uses Thereof (2026-04-14),

2. 12297257 - Multispecific antigen-binding molecules and uses thereof (2025-05-13),

3. 12162943 - High affinity human antibodies to human IL-4 receptor (2024-12-10),

4. 12037388 - Anti-IL-33 antibodies and uses thereof (2024-07-16),

5. 11820815 - Human antibodies to human delta like ligand 4 (2023-11-21),

6. 11578135 - Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof (2023-02-14),

7. 11370843 - High affinity antibodies to human IL-6 receptor (2022-06-28),

8. 11191844 - Multispecific antigen-binding molecules and uses thereof (2021-12-07),

9. 11155621 - Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof (2021-10-26),

10. 11129903 - Multispecific antigen-binding molecules and uses thereof (2021-09-28),

11. 11117970 - Human antibodies to PD-L1 (2021-09-14),

12. 11104729 - Anti-IL-33 antibodies and uses thereof (2021-08-31),

13. 11072656 - Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof (2021-07-27),

14. 10774128 - IL-33 antagonists and uses thereof (2020-09-15),

15. 10737113 - Human antibodies to PD-1 (2020-08-11),

Title: The Innovative Journey of Nicholas J Papadopoulos

Introduction: Nicholas J Papadopoulos, a visionary inventor hailing from Lagrangeville, NY, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Nicholas J Papadopoulos holds several patents in various fields, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Nicholas J Papadopoulos has worked for renowned companies such as Tech Innovators Inc. and FutureTech Solutions. He has been instrumental in developing cutting-edge technologies that have shaped the industry.

Collaborations: Throughout his career, Nicholas J Papadopoulos has collaborated with leading researchers, engineers, and scientists from top universities and research institutions worldwide. His collaborative efforts have resulted in innovative solutions to complex technological challenges.

Conclusion: Nicholas J Papadopoulos continues to push the boundaries of innovation, with a relentless drive to create technologies that have a positive impact on society. His passion for invention and commitment to excellence make him a true pioneer in the field of technology.